Heavier smoking may bring skyrocketing health risks
In a new study, researchers found each cigarette smoked a day by heavier smokers increases the risk of contracting some diseases by more than...
This finding may help create an effective COVID-19 vaccine
Idiopathic inflammatory myopathies, such as dermatomyositis, are a group of diseases characterized by inflamed skeletal muscles that may also involve the lungs, heart, and...
This stuff plays a key role in COVID-19 infection, new study confirms
In a new study, researchers have described the presence, throughout the human body, of the enzyme ACE2.
This is thought to be the key protein...
This blood test can find who will have severe COVID-19 and death
In a new study, researchers found five biomarkers in the blood associated with higher odds of clinical deterioration and death in COVID-19 patients.
The findings...
One more reason to wear a face mask: You’ll get less sick from COVID-19
As states increasingly promote face masks as a way to control the spread of COVID-19, the top-line message has been: Wear a mask to...
This old vaccine may help fight COVID-19, new evidence shows
In a new study, researchers found the BCG vaccine, a vaccine originally made against tuberculosis, has a general stimulating effect on the immune system...
This hormone may increase COVID-19 death risk
The stress hormone cortisol is produced by the body in response to stress such as illness, triggering changes in metabolism, heart function, and the...
COVID-19 death rate is 29% in people with this health problem
In a new study, researchers found for people with multiple myeloma and COVID-19, the fatality rate is 29% among hospitalized patients, with increased odds...
A new COVID-19 vaccine shows promise in preventing COVID-19
In a new study, researchers found that an investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19.
The...
Early use of this drug may benefit people with severe COVID-19
In a new study, researchers found that patients experiencing severe COVID-19 symptoms had improved outcomes when used an Interleukin-6 (IL6ri) inhibitor, sarilumab, or tocilizumab.
The...